PET/MRI of Primary Sclerosing Cholangitis
Public ClinicalTrials.gov record NCT06252610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PET/MRI Evaluation in Patients With Primary Sclerosing Cholangitis Using Intercellular Matrix Radiopharmaceuticals
Study identification
- NCT ID
- NCT06252610
- Recruitment status
- Not yet recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Massachusetts General Hospital
- Other
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Interventions
- Contrast Media, Magnetic Resonance Drug
- Imaging Diagnostic Test
- Radiotracer Injection Drug
Drug · Diagnostic Test
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 9, 2026
- Primary completion
- Apr 29, 2029
- Completion
- Apr 29, 2029
- Last update posted
- Oct 15, 2025
2026 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School | Charlestown | Massachusetts | 02129 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06252610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2025 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06252610 live on ClinicalTrials.gov.